Therapeutic administration (into mice with ∼100 mm3 established tumors) with an isotype control antibody or an anti-PD-1 mAb failed to resolve the disease or have any discernable impact on tumor growth, establishing this tumor model as both “high bar” and PD-1 refractory (Figures 4B,C). The gene discussed is PDCD1; the disease is neoplasm.